Alternatives to Cradle Bio

AI drug discovery engine pairing 2M weekly wet-lab experiments with a 50+ petabyte phenomics dataset

Oncology real-world evidence platform that turns patient data into AI-powered cancer research insights.

AI-driven clinical trial patient matching and recruitment from EMR data.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data for discovery teams.

AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.

Causal AI for human health, turning 20+ petabytes of cellular data into targeted therapeutics.

Dotmatics Luma Agent: agentic AI for multimodal R&D data analysis and scientific workflow automation

AI-driven drug discovery platform with 50+PB proprietary data and automated wet labs

Adaptyv runs automated protein binding, expression, and thermostability assays as fast as 3 days.

AI data analyst for bio labs: raw data to publication-ready results

Open-source benchmark for AI therapeutic decision-making, expanded into software engineering with CueBench for Developers.

Open-source AI research assistant for accelerated drug discovery, self-hosted with full data control

AI-driven health data platform uniting patient care and clinical research

Open data platform for traceable, multimodal biology AI

Domain-specific healthcare data and RL environments for AI

AI real-world evidence generation from clinical data in minutes

Open-source automated model assembly from literature and databases for systems biology

Owkin's K Pro: an autonomous AI scientist for biopharma R&D decision-making

Tech-driven drug discovery and biologics manufacturing platform

Silico: mechanistic interpretability platform to understand, debug, and design AI models

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Generative AI drug discovery platform spanning target ID to clinical trials, with its own Phase III pipeline as proof.

All-in-human AI foundation models for precision neurology and CNS drug discovery

Generative AI and robotics platform compressing drug discovery to under two years.

Physics-based molecular discovery platform for drug and materials design

FDA-cleared AI for cancer pathology diagnostics and biomarker discovery.

Quibim turns MRI, CT, and PET scans into regulatory-cleared quantitative imaging biomarkers for radiology and biopharma

AI cell therapy manufacturing with laser precision and closed-loop control

BenevolentAI: AI drug discovery knowledge graph for target discovery and repurposing

PathAI is an enterprise AI pathology platform for diagnostic accuracy and biopharma drug development.